The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency

Acta Anaesthesiol Scand. 2018 Jul;62(6):874-875. doi: 10.1111/aas.13120. Epub 2018 Apr 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anesthesiology
  • Critical Care
  • Humans
  • Hydroxyethyl Starch Derivatives / adverse effects*
  • Plasma Substitutes / adverse effects*
  • Societies, Medical
  • Solutions

Substances

  • Hydroxyethyl Starch Derivatives
  • Plasma Substitutes
  • Solutions